Cargando…
Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine()()
BACKGROUND: Despite the majority of patients do not gain any benefit from dendritic cells (DC) vaccines, this approach has occasionally given rise to dramatic responses in melanoma. Biomarkers are crucial to identify which patients are more likely to respond. We looked for correlations between pre-...
Autores principales: | Leeman, Hayley, Kaminska, Elwira, Green, Deborah, Bodman-Smith, Mark, Gravett, Andrew, Bodman-Smith, Katherine, Copier, John, Coulton, Gary, Fusi, Alberto, Dalgleish, Angus G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288404/ https://www.ncbi.nlm.nih.gov/pubmed/30530187 http://dx.doi.org/10.1016/j.tranon.2018.11.002 |
Ejemplares similares
-
Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy
por: Fowler, Daniel W., et al.
Publicado: (2011) -
Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2(+) γδ T cell cytotoxicity in a perforin-dependent manner
por: Fowler, Daniel W., et al.
Publicado: (2017) -
The cytotoxic molecule granulysin is capable of inducing either chemotaxis or fugetaxis in dendritic cells depending on maturation: a role for Vδ2(+)
γδ T cells in the modulation of immune response to tumour?
por: Sparrow, Emma L., et al.
Publicado: (2020) -
Supernatants derived from chemotherapy-treated cancer cell lines can modify angiogenesis
por: Liu, W M, et al.
Publicado: (2012) -
T-regulatory cell modulation: the future of cancer immunotherapy?
por: Nizar, S, et al.
Publicado: (2009)